BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM $4.68B
1-Year Return
16.47%
This Quarter Return
-4.1%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$4.19B
AUM Growth
-$365M
(-8%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
46.9%
Holding
204
New
38
Increased
55
Reduced
66
Closed
18
Top Buys
| 1 |
Stryker
SYK
|
+$40M |
| 2 |
AbbVie
ABBV
|
+$16.5M |
| 3 |
Eaton
ETN
|
+$13M |
| 4 |
Procter & Gamble
PG
|
+$9.94M |
| 5 |
Marsh & McLennan
MMC
|
+$8.94M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$37.4M |
| 2 |
PepsiCo
PEP
|
+$33.7M |
| 3 |
Amazon
AMZN
|
+$19.2M |
| 4 |
Visa
V
|
+$16.5M |
| 5 |
Microsoft
MSFT
|
+$13.8M |
Sector Composition
| 1 | Technology | 21.73% |
| 2 | Healthcare | 16.78% |
| 3 | Financials | 16.25% |
| 4 | Consumer Discretionary | 15.23% |
| 5 | Communication Services | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Penumbra
PEN
$10B
| – | – |
-1,092
| Closed | -$259K |
|
202
Pfizer
PFE
$137B
| – | – |
-10,100
| Closed | -$268K |
|
203
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-2,467
| Closed | -$300K |
|
204
SPDR S&P Biotech ETF
XBI
$5.45B
| – | – |
-9,110
| Closed | -$820K |
|